Click here to see Dr. VanderWalde’s curriculum vitae.
The West Clinic welcomes Ari VanderWalde, MD, MPH, MBioeth, as Director of Clinical Research. An internationally-recognized cancer researcher, Dr. VanderWalde will also hold a dual appointment with the University of Tennessee Health Science Center as Associate Vice Chancellor of Research and Assistant Professor, Hematology/Oncology.
Dr. VanderWalde previously served as United States Medical Lead and Clinical Research Medical Director with Amgen Inc., directing U.S. global development of talimogene laherparepvec, a novel viral-based immunotherapeutic that has shown efficacy in late-stage clinical trials in melanoma. As an expert in melanoma, Dr. VanderWalde has collaborated with some of the nation’s thought leaders and participated on advisory boards with top experts in the field.
He will continue to elevate The West Clinic’s long history of clinical research. With a dual appointment at the University of Tennessee Health Science Center, Dr. VanderWalde will help to further integrate translational research and clinical trials in oncology and other areas of internal medicine. He will also be coordinating a renewed focus toward NCI cooperative-sponsored clinical trials in medical oncology, surgical oncology, and radiation oncology.
Dr. VanderWalde received his medical degree in 2005 from the University of Pennsylvania School of Medicine in Philadelphia after graduating cum laude from Harvard University. He obtained Masters degrees from the University of Pennsylvania Center for Bioethics and Harvard School of Public Health. He completed internal medicine training at UCLA (internship and residency) and a joint fellowship in Hematology/Oncology at City of Hope Comprehensive Cancer Center and Harbor-UCLA Medical Center. He is board-certified in Internal Medicine and Medical Oncology.
“I’ve been given an amazing opportunity and set of tools with which to work,” states Dr. VanderWalde. “I hope to use my research and clinical skills as well as my pharmaceutical industry experience to further establish West Cancer Center as a regional center of excellence for the delivery of the best and most up-to-date cancer care. Together, we will continue to grow West Cancer Center’s reputation as a regional center for clinical trial research and in so doing establish best practices to improve the health of our patients.” Dr. VanderWalde has published extensively in the field of cancer as well as in research ethics and has presented at numerous international meetings.